4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Ionis Pharmaceuticals, Inc. (IONS) operates in the Biotechnology industry and is headquartered in Carlsbad, United States with about 1,402 employees. Its market capitalization is roughly $11 billion. In the fiscal year ended 2025-12-31, IONS reported $944M in revenue and ($381M) in net income.
Ionis Pharmaceuticals, Inc., a commercial-stage biotechnology company, provides RNA-targeted medicines in the United States.
Interactive charts & full statements → Open the IONS valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $944M | $705M | $788M | $587M | — |
| Gross Profit | $928M | $694M | $778M | $573M | — |
| Operating Income (EBIT) | ($382M) | ($475M) | ($354M) | ($410M) | — |
| Net Income | ($381M) | ($454M) | ($366M) | ($270M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $246M | $203M | $157M | $452M | $132M |
| Gross Profit | $243M | $195M | $154M | $448M | $130M |
| Operating Income (EBIT) | ($118M) | ($214M) | ($160M) | $140M | ($147M) |
| Net Income | ($92M) | ($229M) | ($129M) | $124M | ($147M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $3.5B | $3.0B | $3.0B | $2.5B | — |
| Total Liabilities | $3.0B | $2.4B | $2.6B | $2.0B | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive IONS viewer.
About TickerBase · Data methodology & sources